3HA-13852-48445
2 vaccinations
4 coded responses
20 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 211 / MD
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat and nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Discharge, Nasal congestion, Upper-airway cough syndrome — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, nasal congestion and drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-22
Survey response — day 7, dose 1MedDRA: Nasal congestion — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-31
- 2021-02-05
-
2021-02-08
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
-
2021-08-09
Survey response — 6 months, dose 2MedDRA: Unevaluable event — Feeling: Good · Be unable to do your normal daily activitiesFree text: Post partumMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-02-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-21 | priority 2/3 | |
| 2021-01-22 | priority 2/3 |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat and nasal congestion
Systemic reaction (other): Cough, nasal congestion and drainage
Release 2 — day 7, dose 1
Systemic reaction (other): Nasal congestion
Release 9 — 6 months, dose 2
Symptoms: Post partum
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | ✓ | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Discharge | ✓ | · | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release